Prabco Surgimed Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 23 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.75 Cr
- Revenue Growth 10.59%
- Profit Growth 17.90%
- Ebitda -2566.40%
- Net Worth 26.32%
- Total Assets 7.77%
About Prabco Surgimed
Prabco Surgimed Private Limited (PSPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 January 2012 and has a history of 13 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.75 Cr.
Praveen Narang, Prabhat Narang, and Kusum Narang serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85190DL2012PTC230138
-
Company No.
230138
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jan 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Prabco Surgimed?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhat Narang
|
Director | 17-Jan-2012 | Current |
|
Praveen Narang
|
Director | 17-Jan-2012 | Current |
|
Kusum Narang
|
Director | 30-Jun-2014 | Current |
Financial Performance of Prabco Surgimed.
Prabco Surgimed Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.59% increase. The company also saw a substantial improvement in profitability, with a 17.9% increase in profit. The company's net worth Soared by an impressive increase of 26.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prabco Surgimed?
Unlock access to Prabco Surgimed's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
City Drugs Private LimitedPraveen Narang and Prabhat Narang are mutual person
Charges (Loans)
₹37.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2020 | Others | ₹3.75 Cr | Open |
How Many Employees Work at Prabco Surgimed?
Unlock and access historical data on people associated with Prabco Surgimed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prabco Surgimed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prabco Surgimed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.